Haemonetics (HAE) Total Liabilities (2010 - 2026)

Haemonetics' Total Liabilities history runs 17 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• In Q1 2026, Total Liabilities fell 1.87% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (down 1.87% YoY), while the FY2026 annual figure was $1.6 billion, down 1.87% from the prior year.
• Total Liabilities was $1.6 billion for Q1 2026 at Haemonetics, up from $1.6 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.6 billion in Q3 2024 to a low of $1.1 billion in Q3 2022.
• Historically, Total Liabilities has averaged $1.3 billion across 5 years, with a median of $1.2 billion in 2023.
• Biggest YoY gain for Total Liabilities was 83.77% in 2022; the steepest drop was 6.0% in 2022.
• A 5-year view of Total Liabilities shows it stood at $1.1 billion in 2022, then advanced by 14.07% to $1.3 billion in 2023, then advanced by 29.22% to $1.6 billion in 2024, then slipped by 2.77% to $1.6 billion in 2025, then gained by 1.28% to $1.6 billion in 2026.
• The last three Total Liabilities figures came in at $1.6 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.